Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0002-5990-9548Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
5 papers
Recent·Most cited
Samarpana Chakraborty, Claudia Morganti, Kimberly S. Zaldana…·Aditi Shastri
This paper shows that targeting STAT3 with a degrader can overcome Venetoclax resistance in AML by reducing MCL1 and improving mitochondrial function.
Ahmed M. Mamdouh, Fang Qi Lim, Yang Mi…·Shruti Bhatt
This study identifies BIRC5 as a targetable vulnerability in TP53 mutant AML, showing that survivin/IAP inhibitors can overcome therapy resistance.
Kashi Raj Bhattarai, Robert J. Mobley, Kelly R. Barnett…·Daniel Savic
The paper identifies noncoding genetic variants affecting chemotherapy response in childhood ALL by linking them to gene regulatory elements and showing functional impacts on drug sensitivity.
Kelly R. Barnett, Robert J. Mobley, Jonathan D. Diedrich…·Daniel Savic
The paper maps chromatin accessibility in B-ALL subtypes using ATAC-seq, identifies TFs and genetic variants influencing chromatin architecture and gene regulation.
Min Wang, Steven Mitchell Kornblau, Kevin R. Coombes
The paper improves PCA for biological data by automating a graphical Bayesian method to identify significant principal components with biological interpretations, applied to proteomics data from acute myeloid leukemia patients.